中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
  4. 新药研究国家重点实验室
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants

文献类型：期刊论文

作者Tu, Bin1,2; Wang, Huiyuan1; An, Xinran1,3; Qu, Jingkun1,4; Li, Qianqian1,5; Gao, Yanrong1,2; Shi, Mingjie1; Qiu, Hong1; Huang, Yongzhuo1,2,6,7,8
刊名ACTA PHARMACEUTICA SINICA B
出版日期2022-07
卷号12期号:7页码:3187-3194
ISSN号2211-3835
关键词SARS-CoV-2 Delta variant Heparan sulfate Spike protein Heparin nanoparticle Pulmonary delivery
DOI10.1016/j.apsb.2022.01.019
文献子类Letter
WOS关键词PHAGOCYTOSIS ; CLEARANCE ; RECEPTOR
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
WOS记录号WOS:000827636300005
源URL[http://119.78.100.183/handle/2S10ELR8/309324]  
专题新药研究国家重点实验室
通讯作者Wang, Huiyuan; Huang, Yongzhuo
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China;
3.Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA;
4.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China;
5.Nanchang Univ, Coll Pharm, Nanchang 330006, Jiangxi, Peoples R China;
6.Chinese Acad Sci, Shanghai Inst Mat Med, Zhongshan Inst Drug Discovery, Zhongshan 528437, Peoples R China;
7.NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipi, Shanghai 201203, Peoples R China;
8.Taizhou Univ, Sch Adv Study, Inst Nat Med & Hlth Prod, Taizhou 318000, Peoples R China
推荐引用方式
GB/T 7714		 Tu, Bin,Wang, Huiyuan,An, Xinran,et al. Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants[J]. ACTA PHARMACEUTICA SINICA B,2022,12(7):3187-3194.
APA Tu, Bin.,Wang, Huiyuan.,An, Xinran.,Qu, Jingkun.,Li, Qianqian.,...&Huang, Yongzhuo.(2022).Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.ACTA PHARMACEUTICA SINICA B,12(7),3187-3194.
MLA Tu, Bin,et al."Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants".ACTA PHARMACEUTICA SINICA B 12.7(2022):3187-3194.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。